| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |